A phase 2, double-blind, randomized, placebo-controlled, parallel-group, multicenter proof-of-concept study to evaluate the safety and efficacy of Rozerem taken in combination with gabapentin for treatment of subjects with chronic insomnia.
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Gabapentin; Ramelteon
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Takeda
- 04 Jun 2010 Additional trial identifier U1111-1114-3348 identified as reported by ClinicalTrials.gov.
- 18 Sep 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 10 Aug 2006 New trial record.